Defense Department To Award Bioterror Testing Platform Contract By Summer
This article was originally published in The Gray Sheet
Executive Summary
The diagnostic platform targeted by the Department of Defense's bioterrorism acquisition process likely will include electrochemiluminescence (ECL) technology, according to DoD
You may also be interested in...
Igen bioterror defense
Origen biothreat environmental detection product contract with Department of Defense's Joint Program Executive Office for Chemical & Biological Defense will bring in $23 mil. over four years and double the firm's biodefense revenues over the next year, Igen says. During FDA's April Science Forum, PEO-CBD said its initial protocol likely would be a Roche Taqman PCR-type device (1"The Gray Sheet" May 5, 2003, p. 10)...
Igen bioterror defense
Origen biothreat environmental detection product contract with Department of Defense's Joint Program Executive Office for Chemical & Biological Defense will bring in $23 mil. over four years and double the firm's biodefense revenues over the next year, Igen says. During FDA's April Science Forum, PEO-CBD said its initial protocol likely would be a Roche Taqman PCR-type device (1"The Gray Sheet" May 5, 2003, p. 10)...
DoD Assays’ Clearance Goals Reveal FDA Accelerated Review Priorities
FDA is assuring the Department of Defense that counterterrorism assays targeted by DoD's acquisitions program are likely priority candidates for the agency's 510(k) clearance process